Daniela Petrò

491 total citations
9 papers, 125 citations indexed

About

Daniela Petrò is a scholar working on Oncology, Hematology and Infectious Diseases. According to data from OpenAlex, Daniela Petrò has authored 9 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Hematology and 3 papers in Infectious Diseases. Recurrent topics in Daniela Petrò's work include Multiple Myeloma Research and Treatments (3 papers), Vitamin C and Antioxidants Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Daniela Petrò is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Vitamin C and Antioxidants Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Daniela Petrò collaborates with scholars based in Italy. Daniela Petrò's co-authors include Fausto Petrelli, Fausto Rossini, Barbara Frigeni, S. Jann, Francesca Lanzani, Laura Mattavelli, Guido Cavaletti, Mara Ghilardi, Mary Cabiddu and Maria Chiara Parati and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medical Virology.

In The Last Decade

Daniela Petrò

8 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Petrò Italy 6 64 53 30 24 14 9 125
Tiphaine Adam de Beaumais France 7 31 0.5× 34 0.6× 20 0.7× 49 2.0× 6 0.4× 20 252
Madhuri Vusirikala United States 7 32 0.5× 129 2.4× 15 0.5× 55 2.3× 8 0.6× 28 191
Charan Thej Reddy Vegivinti United States 6 33 0.5× 25 0.5× 33 1.1× 22 0.9× 15 1.1× 27 109
Steffie van der Werf Netherlands 8 60 0.9× 72 1.4× 15 0.5× 25 1.0× 4 0.3× 15 178
Maximilien Grall France 7 20 0.3× 30 0.6× 26 0.9× 13 0.5× 5 0.4× 17 118
Tushar Sehgal India 6 25 0.4× 30 0.6× 10 0.3× 11 0.5× 3 0.2× 35 81
Joshua Dower United States 5 31 0.5× 24 0.5× 8 0.3× 24 1.0× 4 0.3× 10 107
Karine Augeul-Meunier France 7 46 0.7× 37 0.7× 5 0.2× 23 1.0× 8 0.6× 13 108
Praneeth Reddy Keesari United States 6 39 0.6× 20 0.4× 11 0.4× 25 1.0× 10 0.7× 20 78
Aasiya Matin United States 5 31 0.5× 42 0.8× 17 0.6× 62 2.6× 2 0.1× 18 170

Countries citing papers authored by Daniela Petrò

Since Specialization
Citations

This map shows the geographic impact of Daniela Petrò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Petrò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Petrò more than expected).

Fields of papers citing papers by Daniela Petrò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Petrò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Petrò. The network helps show where Daniela Petrò may publish in the future.

Co-authorship network of co-authors of Daniela Petrò

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Petrò. A scholar is included among the top collaborators of Daniela Petrò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Petrò. Daniela Petrò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ghidini, Antonio, Maria Chiara Parati, Karen Borgonovo, et al.. (2025). Immune Checkpoint Inhibitors Beyond Progression in Various Solid Tumors: A Systematic Review and Pooled Analysis. Journal of Clinical Medicine. 14(18). 6680–6680.
2.
Petrelli, Fausto, Karen Borgonovo, Giuseppina Dognini, et al.. (2024). Vitamin D3 and cancer risk in healthy subjects: An umbrella review of systematic review and meta-analysis. Clinical Nutrition ESPEN. 63. 776–786. 3 indexed citations
3.
Petrelli, Fausto, Karen Borgonovo, Mary Cabiddu, et al.. (2023). Vitamin D3 and COVID-19 Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses. Antioxidants. 12(2). 247–247. 12 indexed citations
4.
Dottorini, Lorenzo, Fausto Petrelli, Antonio Ghidini, et al.. (2023). Oxaliplatin in Adjuvant Colorectal Cancer: Is There a Role in Older Patients?. Journal of Clinical Oncology. 41(18). 3300–3303. 6 indexed citations
5.
Petrelli, Fausto, Andrea Luciani, Karen Borgonovo, et al.. (2022). Third dose of SARS‐CoV‐2 vaccine: A systematic review of 30 published studies. Journal of Medical Virology. 94(6). 2837–2844. 26 indexed citations
6.
Petrelli, Fausto, Michele Ghidini, Antonio Ghidini, et al.. (2021). Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis. Surgery Today. 51(10). 1535–1557. 21 indexed citations
7.
Lanzani, Francesca, Laura Mattavelli, Barbara Frigeni, et al.. (2008). Role of a pre‐existing neuropathy on the course of bortezomib‐induced peripheral neurotoxicity. Journal of the Peripheral Nervous System. 13(4). 267–274. 46 indexed citations
8.
Corso, Alessandro, Luciana Barbarano, Silvia Mangiacavalli, et al.. (2007). Bortezomib with HIG-Dose Dexamethasone as First Line Therapy in Patients with Multiple Myeloma Candidates to High-Dose Therapy.. Blood. 110(11). 3595–3595. 8 indexed citations
9.
Giuliani, Nicola, Francesca Morandi, Sara Tagliaferri, et al.. (2006). The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.. Blood. 108(11). 508–508. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026